Abstract:AIM: To study the expression level and localization of insulin-like growth factor -I receptor (IGF-IR) in HepG2 cells and Chang liver cells, and to observe the effect of anti-IGF-IR monoclonal antibody (alpha IR3) on the growth of HepG2 cells.METHODS: The expression of IGF-IR in HepG2 cells and Chang liver cells was detected by immunohistochemistry. The influences of aIR3 on proliferation and apoptosis were examined by the 3- (4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and electron microscopy, respectively. Flow cytometry (FCM) was applied for the analysis of cell cycle and apoptosis was observed under electron microscope.RESULTS: IGF-IR was located in the membranes of both HepG2 and Chang liver cell lines, and the expression level of IGF-IR was higher in HepG2 cells than in Chang liver cells. Treated with 0.1 mu g/mL alpha IR3 for 48 h in vitro, the cell growth index (GI) of HepG2 cells was significantly higher than that of control (103.41% vs 100%, P < 0.01). However, the alpha IR3 for 24 h at final concentration of 4.0 mu g/mL made the GI of HepG2 cells lower than that of control (93.37% vs 100%, P < 0.01). Compared with control, treated with aIR3 for 48 h at final concentrations ranging from 1.0 mu g/mL to 4.0 mu g/mL markedly reduced the GIs of HepG2 cells (97.63%, 97.16%, 95.13%, 92.53% vs 100%, P < 0.05 or P < 0.01), treated with alpha IR3 for 72 h at final concentrations ranging from 0.2 mu g/mL to 4.0 mu g/mL decreased the GIs of HepG2 cells obviously (95%, 91.63%, 90.77%, 89.84%, 88.51% vs 100%, P < 0.01), and treated with aIR3 for 96 h at final concentrations ranging from 0.5 mu g/mL to 4.0 mu g/mL made GIs of HepG2 cells lower significantly (88.86%, 83.97%, 79.81%, 77.24%, 70.51% vs 100%, P < 0.05 or P < 0.01). Moreover, treated with alpha IR3 from 24 h to 96 h at final concentrations ranging from 0.2 mu g/mL to 4.0 mu g/mL reduced the GI of HepG2 cells from 97.63% to 70.51% in a close- and time-dependent manner. Also, alpha IR3 treatment for 72 h at final concentration from 0.5 mu g/mL to 2.0 mu g/mL increased the proportion of G0/G1 phase cells(61.73%, 67.1%, 83.7%,76.87% vs 44.47%, P < 0.01) and significantly decreased that of S phase cells(28.63%, 25.13%, 15.63%, 23.13% vs 53.17%, P < 0.01), in contrast to the proportion of G2/M phase cells. The apoptotic rates of HepG2 cells were increased more than that of control (7.83%, 16.13%, 21.1%, 37.73% vs 4.13%, P < 0.01).CONCLUSION: The malignant cell phenotype of human hepatocarcinoma cell is related to overexpression of IGF-IR. The blockage of IGF-IR with alpha IR3 may contribute to the inhibition of proliferation and induction of apoptosis in HepG2 cells. (C) 2006 The WJG Press. All rights reserved.

[Inhibitory Effects of Iressa on Hepatocellular Carcinoma Hep-3B and HepG2 Cell Xenografts in Nude Mice].

The effect of IRESSA on H22 mouse hepatocellular carcinoma

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

The Aryl Hydrocarbon Receptor Ligand ITE Inhibits Cell Proliferation and Migration and Enhances Sensitivity to Drug-Resistance in Hepatocellular Carcinoma.

Effect of Blocking IGF-I Receptor on Growth of Human Hepatocellular Carcinoma Cells

[Inhibitory Effect of IGF1R Sirna on the Growth of Human Liver Cancer SMMC7721 Cell Xenograft in Nude Mice].

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Antitumor Effect of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Combined with Cytotoxic Agent on Murine Hepatocellular Carcinoma

Iodine-125 Interstitial Brachytherapy Reduces Tumor Growth Via Warburg Effect Inhibition in Non-Small Cell Lung Cancer A549 ×Enografts.

Inhibitory effect of resveratrol on the growth of A549 cell line xenograft in nude mice

Abstract 818: Modulation of Gene Expression and Cell Cycle Signaling Pathways in Iressa-treated Urinary Bladder Cancer in Rats

Inhibitory Effect of 125I Seed Interstitial Brachytherapy on Human Hepatocarcinoma Cell HepG2 Transplanted Tumor in Nude Mice

Effect of RNAi-mediated IGF1R gene silencing on growth, migration, and invasion of hepatocellular carcinoma cells

Effects of Interferon - Β on Recurrence and Growth of Intrahepatic HCC after Radical Resection in Nude Mice

Efficacy of high dose fractionated irradiation on implanted human hepatocellular carcinoma in nude mice

Anti-angiogenic Effects of Becacizumab Combined with Iressa in Highly Metastatic Human Liver Carcinoma Orthotopic Xenografty: an Experimental Study

High-Dose and Long-Term Therapy with Interferon-Alfa Inhibits Tumor Growth and Recurrence in Nude Mice Bearing Human Hepatocellular Carcinoma Xenografts with High Metastatic Potential

Growth Inhibition of High-Intensity Focused Ultrasound on Hepatic Cancer in Vivo

Effect of targeting IL18-EGF fused protein on the antineoplastic activity in vivo

Study on the Inhibitory Effect of Tyroserleutide on Tumor Growth and Metastasis in Nude Mice Model of Human Hepatocellular Carcinoma Metastasis

Experimental Research on the Inhibitory Effect of IFN-Lambda 3 Combined with Sorafenib on the Growth of Liver Cancer Transplanted into Nude Mice